packageCrizotinib

crizotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Crizotinib is an ALK inhibitor anticancer drug used to treat non-small-cell lung carcinoma and other tumours such as inflammatory myofibroblastic tumour. It is authorised in the European Union and is an approved medicine, used mainly in oncology care.

Summary written by glm-5.3-flash from Wikidata Q5186964 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:crizotinib
ATC codes:L01ED01
DrugBank:DB08865
PubChem CID:11626560
ChEBI:64310
Wikidata:Q5186964
formula:C21H22Cl2FN5O
molar mass:450.339 g/mol (PubChem CID 11626560)
logP:3.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown